Our Commitment to Anti-counterfeiting Initiatives
Safeguarding Patients through Responsible Access to Therapies
Counterfeiting drugs is a serious criminal offense and a major public health risk. Counterfeit medicines may include impurities, incorrect quantities of active and inactive ingredients or contaminants that can lead to serious health issues including death.
In our effort to combat prescription drug counterfeiting, Celgene takes deliberate, proactive steps to strictly enforce the quality and safety of our treatments. Celgene continues to explore and implement new strategies and technological developments to deter counterfeiting. We also work closely with regulatory bodies, law enforcement agencies, our industry peers, and consumer protection authorities worldwide to ensure safe and appropriate access to our therapies.
We strongly encourage patients to obtain our treatments through reputable pharmacies and healthcare providers who are licensed to dispense and distribute medicines.
Learn more about anti-counterfeiting by visiting the organizations below.
The Partnership for Safe Medicines – Sponsored by PhRMA, SafeMedicines.org is group of not-for-profit organizations and individuals that have policies, procedures, or programs to protect consumers from counterfeit or contraband medicines.
The Coalition Against Counterfeiting and Piracy (CACP) – Led by the U.S. Chamber of Commerce’s Global Intellectual Property Center, the CACP aims to fight the growing threat of counterfeiting and piracy to the economy, jobs, and consumer health and safety.
FDA: Combating Counterfeit Drugs – Learn about the U.S. Food & Drug Administration’s programs targeted at counterfeit therapies, news and speeches on counterfeiting, reporting suspected fake medicines, and other helpful resources.
International AntiCounterfeiting Coalition (IACC) – The IACC’s mission is to combat counterfeiting and piracy by promoting laws, regulations, directives, and relationships designed to render the theft of intellectual property undesirable and unprofitable.
European Alliance for Access to Safe Medicines (EAASM) – An independent, pan-European initiative dedicated to protecting patient safety by ensuring access to safe and legitimate medicines, the EAASM offers information for patients and professionals, news articles and reports on counterfeit treatments.
If you suspect your medicine has been tampered with, please report it to your healthcare provider, pharmacist or Celgene immediately.
For more information, please call Celgene Customer Care at 1-888-423-5436, Monday through Friday from 8:00 am to 8:00 pm ET.